Other Species / Isoforms
  PRCC (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

  HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S8
MSLVAYASSDESEPD
0 1
PRCC (human) MSLVAYASSDESEPD S8
PRCC (mouse) MSLVAYASSDDSEPD S8
PRCC (rat) MSLVAYAssDDsEPD S8-p
S9
SLVAYASSDESEPDE
0 1
PRCC (human) SLVAYASSDESEPDE S9
PRCC (mouse) SLVAYASSDDSEPDE S9
PRCC (rat) SLVAYAssDDsEPDE S9-p
S12
AYASSDESEPDEAEP
0 1
PRCC (human) AYASSDESEPDEAEP S12
PRCC (mouse) AYASSDDSEPDEPEP S12
PRCC (rat) AYAssDDsEPDEPEP S12-p
S97-p
FPPPPGVsPAEAAGV
Upstream
0 1
Treatment
  • nocodazole
PRCC (human) FPPPPGVsPAEAAGV S97-p
PRCC (mouse) FPPPAGVSPAEAAGV S99
PRCC (rat) FPPPAGVSPAEAAGV S97
S114-p
GLGLGLPsPRGPGLN
Upstream
0 5
Treatment
  • nocodazole
PRCC (human) GLGLGLPsPRGPGLN S114-p
PRCC (mouse) GEGLGLPSPQGPGLS S114
PRCC (rat) GEGLGLPSPQGPGLS S112
S157-p
PELHKGDsDsEEDEP
Upstream
0 67
Treatment
  • dasatinib
  • ischemia
  • metastatic potential
  • rapamycin
  • Torin1
view more >
PRCC (human) PELHKGDsDsEEDEP S157-p
PRCC (mouse) PELQKGDsDsEEDEP S157-p
PRCC (rat) PELHKGDsDsEEDEP S155-p
S159-p
LHKGDsDsEEDEPtK
Upstream
0 60
Treatment
  • dasatinib
  • ischemia
  • metastatic potential
  • rapamycin
  • Torin1
view more >
PRCC (human) LHKGDsDsEEDEPtK S159-p
PRCC (mouse) LQKGDsDsEEDEPAK S159-p
PRCC (rat) LHKGDsDsEEDEPAK S157-p
T165-p
DsEEDEPtKKKTILQ
Upstream
0 9
Treatment
  • dasatinib
PRCC (human) DsEEDEPtKKKTILQ T165-p
PRCC (mouse) DsEEDEPAKKKVVLQ A165
PRCC (rat) DsEEDEPAKKKVVLQ A163
K207
LPHAFSRKPsDGsPD
0 1
PRCC (human) LPHAFSRKPsDGsPD K207
PRCC (mouse) LPHAFSRKPsDISSD K207
PRCC (rat) LPHAFSRkPSDVSSD K205-ac
S209-p
HAFSRKPsDGsPDTK
Upstream
0 16
Treatment
  • ischemia
PRCC (human) HAFSRKPsDGsPDTK S209-p
PRCC (mouse) HAFSRKPsDISSDAK S209-p
PRCC (rat) HAFSRkPSDVSSDAk S207
S212-p
SRKPsDGsPDTKPSR
Upstream
0 12
Treatment
  • nocodazole
PRCC (human) SRKPsDGsPDTKPSR S212-p
PRCC (mouse) SRKPsDISSDAKPSR S212
PRCC (rat) SRkPSDVSSDAkPSR S210
K216
sDGsPDTKPSRLASK
0 1
PRCC (human) sDGsPDTKPSRLASK K216
PRCC (mouse) sDISSDAKPSRLASK K216
PRCC (rat) SDVSSDAkPSRLASK K214-ac
K225-m1
SRLASKTkTSSLAPV
0 3
PRCC (human) SRLASKTkTSSLAPV K225-m1
PRCC (mouse) SRLASKTKPASLAPV K225
PRCC (rat) SRLASKTKPASLAPV K223
T238-p
PVVGTTTttPsPsAI
0 1
PRCC (human) PVVGTTTttPsPsAI T238-p
PRCC (mouse) PVLGTTTTTPsPSAI T238
PRCC (rat) PVLGTTTTTPSPSAI T236
T239-p
VVGTTTttPsPsAIK
Upstream
0 12
Treatment
  • nocodazole
PRCC (human) VVGTTTttPsPsAIK T239-p
PRCC (mouse) VLGTTTTTPsPSAIK T239
PRCC (rat) VLGTTTTTPSPSAIK T237
S241-p
GTTTttPsPsAIKAA
Upstream
0 20
Treatment
  • ischemia
  • nocodazole
PRCC (human) GTTTttPsPsAIKAA S241-p
PRCC (mouse) GTTTTTPsPSAIKAA S241-p
PRCC (rat) GTTTTTPSPSAIKAA S239
S243-p
TTttPsPsAIKAAAk
0 2
PRCC (human) TTttPsPsAIKAAAk S243-p
PRCC (mouse) TTTTPsPSAIKAAAK S243
PRCC (rat) TTTTPSPSAIKAAAK S241
K250-ac
sAIKAAAkSAALQVT
0 1
PRCC (human) sAIKAAAkSAALQVT K250-ac
PRCC (mouse) SAIKAAAKSAALQVT K250
PRCC (rat) SAIKAAAKSAALQVT K248
T261-p
LQVTKQItQEEDDsD
Upstream
0 21
Treatment
  • metastatic potential
  • UV
PRCC (human) LQVTKQItQEEDDsD T261-p
PRCC (mouse) LQVTKQItQEDDDsD T261-p
PRCC (rat) LQVTKQItQEDDDsD T259-p
S267-p
ItQEEDDsDEEVAPE
Upstream
0 51
Treatment
  • metastatic potential
  • UV
PRCC (human) ItQEEDDsDEEVAPE S267-p
PRCC (mouse) ItQEDDDsDEEVAPE S267-p
PRCC (rat) ItQEDDDsDEEVAPE S265-p
S278-p
VAPENFFsLPEKAEP
0 1
PRCC (human) VAPENFFsLPEKAEP S278-p
PRCC (mouse) VAPENFFSLPDKAEP S278
PRCC (rat) VAPENFFSLPDKAEP S276
K414-sm
EINFVEIkGDDQLSG
0 1
PRCC (human) EINFVEIkGDDQLSG K414-sm
PRCC (mouse) EINFVEIKGDDQLSG K414
PRCC (rat) EINFVEIKGDDQLSG K412
K428-ub
GAQQWMTkSLTEEkT
0 1
PRCC (human) GAQQWMTkSLTEEkT K428-ub
PRCC (mouse) GAQQWMTKSLTEEKT K428
PRCC (rat) GAQQWMTKSLTEEKT K426
K434-ac
TkSLTEEkTMKSFSK
0 1
PRCC (human) TkSLTEEkTMKSFSK K434-ac
PRCC (mouse) TKSLTEEKTMKSFSk K434
PRCC (rat) TKSLTEEKTMKSFSK K432
K441
kTMKSFSKkkGEQPT
0 1
PRCC (human) kTMKSFSKkkGEQPT K441
PRCC (mouse) KTMKSFSkKKGEQPT K441-ac
PRCC (rat) KTMKSFSKKKGEQPT K439
K442-ac
TMKSFSKkkGEQPTG
0 1
PRCC (human) TMKSFSKkkGEQPTG K442-ac
PRCC (mouse) TMKSFSkKKGEQPTG K442
PRCC (rat) TMKSFSKKKGEQPTG K440
K443-ac
MKSFSKkkGEQPTGQ
0 1
PRCC (human) MKSFSKkkGEQPTGQ K443-ac
PRCC (mouse) MKSFSkKKGEQPTGQ K443
PRCC (rat) MKSFSKKKGEQPTGQ K441
Y459-p
RRKHQITyLIHQAKE
0 2
PRCC (human) RRKHQITyLIHQAKE Y459-p
PRCC (mouse) RRKHQITYLIHQAKE Y459
PRCC (rat) RRKHQITYLIHQAKE Y457
K472-ub
KERELELkNTWSENk
0 1
PRCC (human) KERELELkNTWSENk K472-ub
PRCC (mouse) KERELELKNTWSENK K472
PRCC (rat) KERELELKNTWSENk K470
K479
kNTWSENKLSRRQTQ
0 1
PRCC (human) kNTWSENKLSRRQTQ K479
PRCC (mouse) KNTWSENKLSRRQTQ K479
PRCC (rat) KNTWSENkLSRRQTQ K477-ac
K479-ub
kNTWSENkLSRRQTQ
0 2
PRCC (human) kNTWSENkLSRRQTQ K479-ub
PRCC (mouse) KNTWSENKLSRRQTQ K479
PRCC (rat) KNTWSENKLSRRQTQ K477
K488-ub
SRRQTQAkYGF____
0 1
PRCC (human) SRRQTQAkYGF____ K488-ub
PRCC (mouse) SRRQTQAKYGF____ K488
PRCC (rat) SRRQTQAKYGF____ K486